Bayer AG Stock (DE000BAY0017): Dividend Decision Announced

Bayer AG declared a dividend of €13.00 per share for fiscal year 2025, payable in May 2026. The announcement follows the company's annual results release dated April 30, 2026.

Bayer AG announced a dividend of €13.00 per share for fiscal year 2025 on April 30, 2026, according to the company investor relations press release dated April 30, 2026. The payment is scheduled for May 15, 2026, with the ex-dividend date on May 10, 2026.

By the AD HOC NEWS Editorial Team.

Bayer AG's business model in brief

Bayer AG is a global life sciences company focused on pharmaceuticals, consumer health, and crop science. The company generates revenue from prescription medicines, over-the-counter products, and agricultural solutions. Its operations span multiple continents with significant exposure to regulated markets.

What the latest development means for Bayer AG

The dividend declaration of €13.00 per share for fiscal year 2025 marks continuity in shareholder returns, as stated in the Bayer AG investor relations press release dated April 30, 2026. This payout corresponds to the annual results for the period ended December 31, 2025. The decision reflects the company's cash generation capabilities post its annual reporting.

Shareholders of record as of May 10, 2026, will be eligible for the payment on May 15, 2026. Bayer AG's board approved this distribution following review of the fiscal 2025 financials.

Why Bayer AG matters for U.S. investors

Bayer AG trades as an ADR on U.S. exchanges under the ticker BAYRY, providing U.S. investors direct access to its shares. The company maintains substantial operations in the United States, including research facilities and sales in pharmaceuticals and crop science. Its products are integral to U.S. agriculture and healthcare sectors.

U.S. regulatory filings and SEC disclosures ensure transparency for American investors. Bayer AG's global revenue includes meaningful contributions from North American markets.

Risks and open questions for Bayer AG

Dividend sustainability depends on future earnings and cash flows amid litigation risks in the pharmaceuticals segment and volatile commodity prices in crop science. Regulatory approvals for new products remain uncertain. Currency fluctuations impact reported euro-denominated results for dollar-based investors.

Bottom line

Bayer AG's dividend declaration of €13.00 per share for fiscal 2025, announced April 30, 2026, underscores its commitment to returning capital to shareholders amid its annual results cycle.

Disclaimer: This is not investment advice. Stocks are volatile financial instruments.